Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sankyo Pharma Gmbh
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age: 18 (19 if required by local authorities) to 75 years
Males and females of any race. Female participants must take adequate contraceptive measures (oral contraceptives, I.U.D.), be post-menopausal or surgically sterilized
Essential hypertension: sitting DBP greater than or equal to 90 and less than 110 mmHg
Written Informed Consent
Mentally competent
Negative pregnancy test in women at a childbearing age at the beginning of the study
You may not be if
Patients with known severe (World Health Organization (WHO) stage III, sitting DBP stable at greater than or equal to 110 mmHg), malignant or secondary hypertension
Patients who have had a myocardial infarction or percutaneous transluminal coronary angioplasty (PTCA) or coronary artery bypass graft (CABG) within the last 6 months
Patients with a history or current evidence of congestive heart failure
Bilateral renal artery stenosis
Severe renal insufficiency (serum creatinine greater than 200 micro mol/l)